BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 19379289)

  • 1. Exogenous melatonin for sleep problems in individuals with intellectual disability: a meta-analysis.
    Braam W; Smits MG; Didden R; Korzilius H; Van Geijlswijk IM; Curfs LM
    Dev Med Child Neurol; 2009 May; 51(5):340-9. PubMed ID: 19379289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin treatment in individuals with intellectual disability and chronic insomnia: a randomized placebo-controlled study.
    Braam W; Didden R; Smits M; Curfs L
    J Intellect Disabil Res; 2008 Mar; 52(Pt 3):256-64. PubMed ID: 18261024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin decreases daytime challenging behaviour in persons with intellectual disability and chronic insomnia.
    Braam W; Didden R; Maas AP; Korzilius H; Smits MG; Curfs LM
    J Intellect Disabil Res; 2010 Jan; 54(1):52-9. PubMed ID: 19888921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin for chronic insomnia in Angelman syndrome: a randomized placebo-controlled trial.
    Braam W; Didden R; Smits MG; Curfs LM
    J Child Neurol; 2008 Jun; 23(6):649-54. PubMed ID: 18539989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities.
    Wasdell MB; Jan JE; Bomben MM; Freeman RD; Rietveld WJ; Tai J; Hamilton D; Weiss MD
    J Pineal Res; 2008 Jan; 44(1):57-64. PubMed ID: 18078449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological treatment of sleep disturbance in developmental disabilities: a review of the literature.
    Hollway JA; Aman MG
    Res Dev Disabil; 2011; 32(3):939-62. PubMed ID: 21296553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin and sleep disorders associated with intellectual disability: a clinical review.
    Sajith SG; Clarke D
    J Intellect Disabil Res; 2007 Jan; 51(Pt 1):2-13. PubMed ID: 17181598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of exogenous melatonin on sleep: a meta-analysis.
    Brzezinski A; Vangel MG; Wurtman RJ; Norrie G; Zhdanova I; Ben-Shushan A; Ford I
    Sleep Med Rev; 2005 Feb; 9(1):41-50. PubMed ID: 15649737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin in wake-sleep disorders in children, adolescents and young adults with mental retardation with or without epilepsy: a double-blind, cross-over, placebo-controlled trial.
    Coppola G; Iervolino G; Mastrosimone M; La Torre G; Ruiu F; Pascotto A
    Brain Dev; 2004 Sep; 26(6):373-6. PubMed ID: 15275698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of melatonin to treat sleep disorder in adults with intellectual disabilities in community settings - the evaluation of three cases using actigraphy.
    Dodd A; Hare DJ; Arshad P
    J Intellect Disabil Res; 2008 Jun; 52(Pt 6):547-53. PubMed ID: 18444986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of strategies for treating sleep problems in persons with severe or profound mental retardation or multiple handicaps.
    Lancioni GE; O'Reilly MF; Basili G
    Am J Ment Retard; 1999 Mar; 104(2):170-86. PubMed ID: 10207580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems.
    Garstang J; Wallis M
    Child Care Health Dev; 2006 Sep; 32(5):585-9. PubMed ID: 16919138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous melatonin predicts efficacy of exogenous melatonin in consolidation of fragmented wrist-activity rhythm of adult patients with developmental brain disorders: a double-blind, placebo-controlled, crossover study.
    Laakso ML; Lindblom N; Leinonen L; Kaski M
    Sleep Med; 2007 Apr; 8(3):222-39. PubMed ID: 17368097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin Treatment in Children with Developmental Disabilities.
    Schwichtenberg AJ; Malow BA
    Sleep Med Clin; 2015 Jun; 10(2):181-7. PubMed ID: 26055866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Melatonin treatment of sleep disorders in disabled children].
    Ramstad K; Loge JH
    Tidsskr Nor Laegeforen; 2002 Apr; 122(10):1009-11. PubMed ID: 12082692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged-release melatonin for children with neurodevelopmental disorders.
    De Leersnyder H; Zisapel N; Laudon M
    Pediatr Neurol; 2011 Jul; 45(1):23-6. PubMed ID: 21723455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin for primary insomnia?
    Drug Ther Bull; 2009 Jul; 47(7):74-7. PubMed ID: 19567841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Controlled release melatonin (Circadin) in the treatment of insomnia in older patients: efficacy and safety in patients with history of use and non-use of hypnotic drugs].
    Zisapel N
    Harefuah; 2009 May; 148(5):337-41, 348. PubMed ID: 19630367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of melatonin on sleep quality after laparoscopic cholecystectomy: a randomized, placebo-controlled trial.
    Gögenur I; Kücükakin B; Bisgaard T; Kristiansen V; Hjortsø NC; Skene DJ; Rosenberg J
    Anesth Analg; 2009 Apr; 108(4):1152-6. PubMed ID: 19299778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Termination of short term melatonin treatment in children with delayed Dim Light Melatonin Onset: effects on sleep, health, behavior problems, and parenting stress.
    van Maanen A; Meijer AM; Smits MG; Oort FJ
    Sleep Med; 2011 Oct; 12(9):875-9. PubMed ID: 21925946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.